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ABSTRAK
Efusi pleura dapat  merupakan presentasi pertama dari keganasan hematologi. Di antara gangguan yang 
paling umum adalah limfoma hodgkin dan limfoma non-hodgkin, dengan frekuensi 20 sampai 30%, terutama 
jika terdapat keterlibatan mediastinum. Leukemia akut dan kronis jarang disertai dengan keterlibatan pleura. 
Kami melaporkan  wanita 46 tahun dengan sesak nafas yang progresif. Pemeriksaan fisik ditemukan dengan 
efusi pleura kiri masif. Hitung darah lengkap menunjukkan anemia, trombositopenia, dan hitung leukosit normal 
. Tes serologi virus menunjukkan HBsAg  dan antiHBc total positif . Foto torak menunjukkan efusi pleura kiri. 
Pemeriksaan sitologi cairan pleura didapatkan mieloblast. Aspirasi sumsum tulang, biopsi sumsum tulangi 
dan analisis flowcytometry sesuai dengan leukemia myeloid akut tanpa maturasi (AML M0- klasifikasi FAB).
Kata kunci: leukemia myeloid akut, efusi pleura, infeksi.
ABSTRACT  
Pleural effusions can be the first presentation of a hematologic malignancy. The most common disorders 
with pleural effusion are Hodgkin and non-Hodgkin lymphoma with a frequency of 20 to 30%, especially if 
mediastinal involvement. Acute and chronic leukemia are rarely accompanied by pleural involvement. We describe 
a 46-year-old female  with  history of progressive dyspnoea. Physical examination was revealed  massive left 
pleural effusion. Complete blood count revealed  anemia, trombositopenia and normal leucocyte count. Viral 
serology test shown positive of  HBsAg and total antiHBc. Chest X-ray revealed left pleural effusion. Pleural 
fluid cytology was myeloblast consistent with acute myeloid leukemia (AML). Bone  marrow aspiration smear, 
bone marrow biopsy smear, and flow cytometry  analysis were consistent with acute myeloid leukemia without 
maturation (AML M0-FAB classification).
Key words: Acute myeloid leukemia, pleural effusion, infection.
INTRODUCTION
Nearly all hematologic malignancies can 
present with pleural effusions. The most 
common disorders with plural effusin are 
Hodgkin and non-Hodgkin lymphomas, with 
a frequency of 20 to 30%, especially if there 
is mediastinal involvement. Acute and chronic 
leukemias, myelodysplastic syndromes, are 
rarely accompanied by pleural involvement. 
Furthermore, 10 to 30% of patients receiving 
bone marrow transplantation develop pleural 
effusions. In cases of hematologic pleural 
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effusions, should be carefully sought the drug 
toxicity, underlying infectious, secondary 
malignant or rarely autoimmune causes. In most 
cases, the pleural fluid responds to treatment 
for the primary disease and if there are clinical 
worsening may necessitate pleurodesis.1,2
CASE ILLUSTRATION
A 46-year-old female was admitted to 
hospital with history of progressive dyspnea for 
two weeks. The onset of thes symptoms were 
insidious, gradually progressive. There was 
history of fever, cough, weakness and loss of 
appetite. Previously patient was hospitalized at 
district hospital for 3 days.
Physical examination of patient revealed 
tachypnoeia and tachycardia. The conjunctival 
palpebrae were pale. There were echimosis 
on the hand, enlarged of right inguinal lymph 
nodes. There were no sternal tenderness and gum 
hypertrophy. Chest examination showed severe 
left side pleural effusion.
Complete blood count revealed haemoglobin: 
6,60 g/dL, leukocyte : 4300/mm3, platelets : 
10.000/mm3, hematocrit : 21,5%. The differential 
count were eosinophils 0% / basophils 0% / band 
neutrophils 0% / segmented neutrophils 41% / 
lymphocytes 43% /Monocytes 2%. Peripheral 
blood smear were erythroblast, myelocyte and 
atypical mononuclear cells.
The biochemical analysis were glucose 149 
mg/dL, urea 23 mg/dl, creatinine 0,88 mg/dl, 
lactate dehydrogenase 221 U/L, uric acid 4,20 
mg/dL, total protein 6,9 gr/dL, albumin 2,8 
gr/dL, AST 48 U/L. The viral serology were 
HBsAg positive, total anti HBc positive. The 
prothrombine time (PPT) were 14,5” (control 
13”) and activated partial thromboplastin time 
(aPTT) was 31,4” (control 29,3”).
The anteroposterior and lateral chest X-ray 
were consistent with severe left side pleural 
effusion. Abdomen ultrasonography showed no 
hepatosplenomegaly.
Bone marrow aspiration revealed 30% 
myeloblasts ,  no maturat ion (M0-FAB 
classification) (Figure 1). Bone marrow biopsy 
revealed >50% myeloblasts (Figure 2). Pleural 
fluid cytology contained myeloblast. (Figure 
3). Flow cytometry analysis was consistent 
with acute myeloid leukemia (positive of CD34, 
cyMPO and CD7). Pleural fluid culture showed 
Staphylococcus aureus (MSSA/Methicillin-
sensitive Staphylococcus aureus).
The patient underwent theraupeutic 
thoracentesis (1000 mL) with platelet transfusions 
prophylaxis. Packed red cell (PRC) tansfusion 
Myelosit
Myeloblast
Figure 1. Bone marrow aspiration smear demonstrating 
myeloblast (HE, 400x)
Myeloblast
Figure 2. Bone marrow biopsy smear demonstrating 
myeloblast (HE, 400x)
Myeloblast
Figure 3. Pleural fluid cytology showing myeloblast (cystopin, 
400x)
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was given after bone marrow aspiration and 
biopsy procedure. Broad spectrum antibiotic 
(ceftriaxone 2 gr iv daily) was given for 
community acquired pneumonia.
After four weeks therapy with thoracentesis 
and ceftriaxon, there were clinical improvement. 
The anteroposterior and lateral of chest X-ray 
showed reduction of pleural pleural effusion 
(Figure 4, Figure 5).
She was planned treatment with 3+7 AML 
protocol (100 mg/m2 cytarabin for 7 days and 
45 mg/m2 daunorubicin for 3 days). Prophylactic 
antiviral therapy using lamivudine 100 mg p.o 
qd for reduction of hepatitis B virus reactivation 
following cytotoxic chemotherapy . She refused 
chemoterapy because of economical reason and 
dischrge home with supportive care.
DISCUSSION
The manifestation of pleural effusion can be 
as a hematological malignancy or complication. 
The possible pathogenesis are extramedullary 
proliferation of occult leukemic clone or a 
subclinical marrow relapse to extramedullary 
sites.1 The other causes of pleural effusion 
were infections,disseminated of solid tumor, or 
complications of treatment.2
The most common disorders are Hodgkin and 
non-Hodgkin lymphomas, with a frequency of 
20 to 30%, especially mediastinal involvement. 
Acute and chronic leukemias are rarely 
accompanied by pleural involvement.1 Acute 
myeloid leukemia with pleural effusion is a very 
rare condition.2-5
The pleural infiltration of acute leukemias 
is rarely diagnosed during life, it is a common 
finding at autopsy. The presence of leukemic 
infiltrates in other tissues in patients with acute 
leukemias were found at autopsy in 10 of 15 
patients who died of an unrelated cause, during 
complete bone marrow remission.1 Besides 
direct infiltration of leukemic cells in the pleura, 
pleural effusion can be secondarily caused by 
drug toxicity, underlying infections, secondary 
malignant or rarely autoimmune causes in 
hematologic malignancies.6
The presence of a pleural effusion in a 
patient with a hematologic malignancy always 
presents a diagnostic challenge. The effusion 
is very small and thoracentesis is typically 
considered. If fever is present, thoracentesis 
is usually performed to exclude infection 
and  parapneumonic effusion or empyema. 
Performing a thoracentesis has a high risk for 
some patients with hematologic malignancies 
because of coagulation abnormalities and 
multiple medical comorbidities. The main 
indication of thoracentesis was to detect an 
infection, relieve dyspnea and cancer restaging.7,8
The pleural effusion in patients with acute 
leukemia usually disappears after induction 
chemotherapy. However, recurrence of pleural 
Figure 4. Anteroposterior chest X-ray showed masive left 
sided pleural effusion
Figure 5. Anteroposterior chest X-ray four weeks after 
therapy showed reduction of pleural  effusion
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exudates is almost inevitable if patients do 
not achieve remission; they may present 
with respiratory failure due to massive fluid 
accumulation. In this circumstance, treatment 
or palliation of pleural disease by intrapleural 
chemotherapy or chemical sclerosis is impeded.1
Reactivation of HBV replication with 
increase in serum HBV DNA and ALT levels 
has been reported in 20% to 50% of hepatitis 
B carriers undergoing immunosuppressive or 
cancer chemotherapy. In most instances, the 
hepatitis flares are asymptomatic, but icteric 
flares, and even hepatic decompensation and 
death have been observed. Clinical studies 
including two controlled trials showed that 
prophylactic therapy with lamivudine can reduce 
the rate of HBV reactivation.9.10
HBsAg and antiHBc testing should be 
performed in persons who have high risk of HBV 
infection, prior to initiation of chemotherapy. 
Prophylactic antiviral therapy should be 
administered to hepatitis B carriers (regardless 
of baseline serum HBV DNA levels) before 
and during chemotherapy, and maintainance 
treatment for 6 months.10-12
CONCLUSION
Pleural effusion can be a presentation of 
hematology malignancy or a complication. 
Pleural fluid should analysis for culture and 
cytology in suspected patient with hematology 
malignancy.
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